517 related articles for article (PubMed ID: 15555704)
21. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
Okazaki M; Tominaga K; Higuchi H; Utagawa I; Nakamura E; Noguchi M; Itaya M; Hashimoto C; Yamaguchi N
J ECT; 2010 Jun; 26(2):87-90. PubMed ID: 19710622
[TBL] [Abstract][Full Text] [Related]
22. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
[TBL] [Abstract][Full Text] [Related]
23. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
Burke MJ; Husain MM
J ECT; 2006 Sep; 22(3):218-22. PubMed ID: 16957540
[TBL] [Abstract][Full Text] [Related]
24. [Continuation ECT].
Sartorius A; Henn FA
Psychiatr Prax; 2005 Nov; 32(8):408-11. PubMed ID: 16308805
[TBL] [Abstract][Full Text] [Related]
25. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
[TBL] [Abstract][Full Text] [Related]
26. Can cognitive behavioral therapy reduce relapse rates of depression after ECT? a preliminary study.
Fenton L; Fasula M; Ostroff R; Sanacora G
J ECT; 2006 Sep; 22(3):196-8. PubMed ID: 16957536
[TBL] [Abstract][Full Text] [Related]
27. Long-term weekly continuation electroconvulsive therapy: a case series.
Zisselman MH; Rosenquist PB; Curlik SM
J ECT; 2007 Dec; 23(4):274-7. PubMed ID: 18090702
[TBL] [Abstract][Full Text] [Related]
28. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
29. Does power matter with ECT?
Ju MR; Birkenhäger TK; van den Broek WW
J Affect Disord; 2005 Dec; 89(1-3):213-6. PubMed ID: 16257059
[TBL] [Abstract][Full Text] [Related]
30. TPH2 polymorphisms may modify clinical picture in treatment-resistant depression.
Anttila S; Viikki M; Huuhka K; Huuhka M; Huhtala H; Rontu R; Lehtimäki T; Leinonen E
Neurosci Lett; 2009 Oct; 464(1):43-6. PubMed ID: 19679166
[TBL] [Abstract][Full Text] [Related]
31. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy.
Shapira B; Gorfine M; Lerer B
Convuls Ther; 1995 Jun; 11(2):80-5. PubMed ID: 7552058
[TBL] [Abstract][Full Text] [Related]
32. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
[TBL] [Abstract][Full Text] [Related]
33. Rehospitalization rate after continued electroconvulsive therapy--a retrospective chart review of patients with severe depression.
Nordenskjöld A; von Knorring L; Engström I
Nord J Psychiatry; 2011 Feb; 65(1):26-31. PubMed ID: 20482461
[TBL] [Abstract][Full Text] [Related]
34. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
35. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
Baghai TC; Marcuse A; Brosch M; Schüle C; Eser D; Nothdurfter C; Steng Y; Noack I; Pietschmann K; Möller HJ; Rupprecht R
World J Biol Psychiatry; 2006; 7(2):82-90. PubMed ID: 16684680
[TBL] [Abstract][Full Text] [Related]
36. Predictors of remission in 208 drug-resistant depressive patients treated with electroconvulsive therapy.
Medda P; Mauri M; Toni C; Mariani MG; Rizzato S; Miniati M; De Simone L; Perugi G
J ECT; 2014 Dec; 30(4):292-7. PubMed ID: 24625706
[TBL] [Abstract][Full Text] [Related]
37. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
[TBL] [Abstract][Full Text] [Related]
38. The definition and meaning of treatment-resistant depression.
Sackeim HA
J Clin Psychiatry; 2001; 62 Suppl 16():10-7. PubMed ID: 11480879
[TBL] [Abstract][Full Text] [Related]
39. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
[TBL] [Abstract][Full Text] [Related]
40. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
Rasmussen KG; Knapp RG; Biggs MM; Smith GE; Rummans TA; Petrides G; Husain MM; O'Connor MK; Fink M; Kellner CH
J ECT; 2007 Dec; 23(4):244-50. PubMed ID: 18090697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
